| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A contentious FDA ruling for Alzheimer's disease
|
The Lancet Neurology,
|
|
|
20 |
8 |
p. 585
|
artikel
|
| 2 |
Ahead of Alzheimer's disease
|
Vannini, Patrizia
|
|
|
20 |
8 |
p. 604
|
artikel
|
| 3 |
Anli Liu
|
|
|
|
20 |
8 |
p. 602
|
artikel
|
| 4 |
Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder
|
Miglis, Mitchell G
|
|
|
20 |
8 |
p. 671-684
|
artikel
|
| 5 |
BK virus-specific T cells for immunotherapy of progressive multifocal leukoencephalopathy: an open-label, single-cohort pilot study
|
Cortese, Irene
|
|
|
20 |
8 |
p. 639-652
|
artikel
|
| 6 |
Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study
|
Fagan, Anne M
|
|
|
20 |
8 |
p. 615-626
|
artikel
|
| 7 |
Correction to Lancet Neurol 2021; 20: 526–36
|
|
|
|
20 |
8 |
p. e5
|
artikel
|
| 8 |
Correction to Lancet Neurol 2021; 20: 437–47
|
|
|
|
20 |
8 |
p. e5
|
artikel
|
| 9 |
Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study
|
Carmona-Iragui, Maria
|
|
|
20 |
8 |
p. 605-614
|
artikel
|
| 10 |
Fluid balance and outcome in critically ill patients with traumatic brain injury (CENTER-TBI and OzENTER-TBI): a prospective, multicentre, comparative effectiveness study
|
Wiegers, Eveline Janine Anna
|
|
|
20 |
8 |
p. 627-638
|
artikel
|
| 11 |
Fluid therapy after brain injury: the pendulum swings again
|
Kochanek, Patrick M
|
|
|
20 |
8 |
p. 587-589
|
artikel
|
| 12 |
Hope for progressive multifocal leukoencephalopathy
|
Clifford, David B
|
|
|
20 |
8 |
p. 589-591
|
artikel
|
| 13 |
Identifying the best biomarkers for α-synucleinopathies
|
Dauvilliers, Yves
|
|
|
20 |
8 |
p. 593-594
|
artikel
|
| 14 |
Intraparenchymal haemorrhages as a primary outcome measure
|
Goyal, Mayank
|
|
|
20 |
8 |
p. 595
|
artikel
|
| 15 |
Intraparenchymal haemorrhages as a primary outcome measure – Authors' reply
|
Maïer, Benjamin
|
|
|
20 |
8 |
p. 595-596
|
artikel
|
| 16 |
Journey down memory lane
|
Warming, Hannah K
|
|
|
20 |
8 |
p. 602
|
artikel
|
| 17 |
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
|
Wattjes, Mike P
|
|
|
20 |
8 |
p. 653-670
|
artikel
|
| 18 |
Management of Alzheimer's disease takes a leap forward
|
Frisoni, Giovanni B
|
|
|
20 |
8 |
p. 586-587
|
artikel
|
| 19 |
Modelling dementia
|
Samarasekera, Udani
|
|
|
20 |
8 |
p. 599-600
|
artikel
|
| 20 |
Off-label use of aducanumab for cerebral amyloid angiopathy
|
Greenberg, Steven M
|
|
|
20 |
8 |
p. 596-597
|
artikel
|
| 21 |
Redefining use of MRI for patients with multiple sclerosis
|
Kira, Jun-ichi
|
|
|
20 |
8 |
p. 591-592
|
artikel
|
| 22 |
The falling and rising of father and son
|
Morgan, Jules
|
|
|
20 |
8 |
p. 603
|
artikel
|
| 23 |
V Wee Yong: a journey of rediscovery
|
Kirby, Tony
|
|
|
20 |
8 |
p. 601
|
artikel
|
| 24 |
World Brain Day 2021: a call to stop multiple sclerosis
|
Wijeratne, Tissa
|
|
|
20 |
8 |
p. 597-598
|
artikel
|
Tijdschrift beschrijving